| NCT07119073 | In-clinic Crossover Study in Subjects With Two Treatments (Fed vs Fasted) | COMPLETED | PHASE1 | 2024-10-31 | 2024-12-27 | 2024-12-21 |
| NCT05924594 | Phase 3 Efficacy and Safety Laboratory Classroom Study in Pediatrics (6-12) With ADHD Using CTx-1301 | SUSPENDED | PHASE3 | 2023-07-31 | 2026-03 | 2026-03 |
| NCT05286762 | Phase 3 Efficacy and Safety Fixed-Dose Study in Pediatrics (6-17) With ADHD Using CTx-1301 | COMPLETED | PHASE3 | 2023-07-25 | 2024-01-24 | 2024-01-24 |
| NCT05631626 | Phase 3 Efficacy and Safety Study in Adults With ADHD Using CTx-1301. | COMPLETED | PHASE3 | 2022-12-29 | 2023-06-13 | 2023-06-13 |
| NCT04449250 | Fed-Fast Crossover Study to Assess the Effect of Food With CTx-1301 in Healthy Subjects | COMPLETED | PHASE1 | 2022-09-14 | 2022-10-14 | 2022-10-14 |
| NCT04138498 | CTx-1301 Comparative Bioavailability Study | COMPLETED | PHASE1, PHASE2 | 2019-12-06 | 2020-03-06 | 2020-03-06 |